|
Neuro Therapeutics Inc.
About Neuro Therapeutics Inc. Nti Has Developed Two New Proprietary Technologies That Target G-protein Coupled Receptors (Gpcrs). Gpcrs Have Long Proven To Be Clinically Relevant Drug Targets. They Account For Nearly Half Of All The Pharmaceutical Drugs On The Market And Drugs... Site: www.neurotherapeutics.com |
|
|||||||